Laura Dolbow
 |
401 UCB
2450 Kittredge Loop Road
Wolf Law Building
Boulder, CO 80309
Office: 463
Phone: (303) 492-3531
E-mail: laura.dolbow@colorado.edu
Curriculum Vitae: View (PDF format)
Bio:Laura Dolbow researches the intersection of patent law, health law, and administrative law.
Her work has been published or is forthcoming in the Michigan Law Review, the Vanderbilt Law Review, and the Administrative Law Review. Her law school note won a 2018 Burton Award for Distinguished Legal Writing and was cited by the Patent Office in a final rule regarding claim construction standards in post-grant review proceedings. Her article, Agency Adherence to Legislative History, won the 2017 Gellhorn-Sargentich Law Student Essay Competition and the Weldon B. White Prize.
Before joining Colorado Law, Dolbow currently was a Sharswood Fellow at Penn Carey Law. She practiced in the appellate and patent litigation groups at Covington & Burling LLP in Washington, DC. She clerked for Judge Judith Rogers on the U.S. Court of Appeals for the D.C. Circuit and for Judge Timothy Dyk on the U.S. Court of Appeals for the Federal Circuit. She received her J.D. and B.A. from Vanderbilt University, where she won the Founder's Medal for her law school class and served as Senior Articles Editor of the Vanderbilt Law Review. Before law school, she taught middle school math through Teach for America in Nashville, TN.
Forthcoming
| Public Patent Powers, 123 MICH. L. REV. __ (forthcoming). |
Articles
| Barring Judicial Review, 77 VAND. L. REV. 307 (2024). |
| Agency Adherence to Legislative History, 70 ADMIN. L. REV. 569 (2018). |
| Note, A Distinction Without a Difference: Convergence in Claim Construction Standards, 70 VAND. L. REV. 1071 (2017). |
Online Essays
| Access Barriers Remain After Abortion Pill Decision, THE REGULATORY REVIEW (July 17, 2024). |
| How Patents Contribute to High Drug Prices, THE REGULATORY REVIEW (October 16, 2023). |
| Patents Do Not Bar Public Pharma Policies, THE REGULATORY REVIEW (July 10, 2023). |
| Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims, BILL OF HEALTH (June 15, 2023). |
| Patent Law Could Also Limit Mifepristone Access, THE REGULATORY REVIEW (April 22, 2023). |
| FDA's Role in Access to Reproductive Health Care, THE REGULATORY REVIEW (April 17, 2023). |
| Judicial Review Bars in the Patent System, Medicare, and Beyond, NOTICE & COMMENT BLOG (March 31, 2023). |
| Congressional Appropriation of Administrative Guidance, 43 ADMIN. & REG. L. NEWS 11 (Winter 2018). |
| Introduction: The Power of New Data and Technology, 70 VAND. L. REV. 1935 (2017) (invited contribution). |
Selected Press, Media & Publicity
Courses:
| Spring 2025 | Property | LAWS 5624-803 |
| Fall 2024 | Sem: Special Topics in Law | LAWS 8002-804 |